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Abstract: Gold nanoparticles functionalized with Gd3+ chelates displaying fast water exchange, 
superb pH stability and inertness towards transmetalation with Zn2+ have been prepared and 
characterized as a new high relaxivity (29 mM-1s-1, 30 MHz, 25 ºC) Contrast Agent potentially 
safe for in vivo MRI applications. The Lipari-Szabo treatment for internal rotation was used to 
evaluate the effect of linker flexibility on the relaxivity of the gold nanoparticles. The relaxivity 
is limited by chelate flexibility. The effect of fast water exchange on the relaxivity of gold 
nanoparticles functionalized with Gd3+ chelates is also addressed in this communication. 
Magnetic Resonance Imaging (MRI) is at the forefront of biomedical and 
clinical imaging. Its superb spatial resolution, non invasive nature and use of benign 
radiation outweigh its intrinsic low detection sensitivity. Paramagnetic relaxers can 
enhance dramatically the contrast between healthy and diseased tissues (Contrast 
Agents, CA´s) by shortening the relaxation times of the water protons in their vicinity. 
The selective reduction of the relaxation times of the water protons brought about by a 1 
mM concentration of paramagnetic centers, relaxivity (units mM-1.s-1), measures the 
efficacy of CAs.1,2 Gd3+ chelates are the most efficacious CAs for MRI. The Solomon-
Bloembergen-Morgan (SBM) theory has established the physical-chemical principles 
guiding the design and synthesis of a plethora of CAs:3 multimeric, self-assembling, 
targeted, responsive, etc. Nonetheless, the predicted high relaxivities, of the order of 
magnitude 100 mM-1s-1, are still to be achieved.  
Nanotechnology is a promising new paradigm in Science and in biomedicine in 
particular. Different nanoplatforms (nanoparticles, quantum dots, fullerenes, carbon 
nanotubes, viral capsules) have been used to improve the performance of CAs by 
integrating (intrinsic) reporting capabilities with properties inherent to nanosize and its 
interplay with biological systems and barriers.4  
There is extensive accumulated experience on the use of Au compounds and 
colloidal (metallic) Au in medicinal chemistry. The accepted biocompatibility of gold 
allied to its resistance to oxidation and facile preparation of nanostructures displaying 
tunable size, shape (nanoparticles, nanorods) and surface properties, makes Au-NPs 
ideal objects for developing multifunctional CAs.5  
Clustering of reporters on the surface of gold NPs (multimerisation) can lead to 
dramatic enhancements of detection sensitivity. Mixed monolayer nanoparticles 
containing reporters and targeting moieties allow integrating multimodality, targeting, 
imaging, and therapy (e.g. hyperthermia) in the same platform- theragnostics. 
Au NPs functionalized with Gd3+ chelates are promising high relaxivity CAs for 
MRI.6 Spectacular relaxivities per nanoparticle (high density of relaxivity) have been 
attained by chelate clustering (multimerisation). Still, relaxivity enhancement per Gd3+ 
chelate is, in most cases, only moderate.7,8 This has been ascribed to suboptimal τR 
resulting from inefficient coupling of global (whole particle) and (independent) local 
rotational motions due to linker flexibility. Large surface curvature (small 
nanoparticles) and/or geometric constraints related to ligand structure prevent efficient 
monolayer packing, which would otherwise restrict linker/spacer flexibility.9,10 Helm 
and co-workers have reported so far, the most impressive relaxivity per Gd3+chelate 
immobilized on gold nanoparticles, 60 mM-1.s-1 (30 MHz, 25 ºC), using Gd3+ chelates of 
DTTA-type ligands.11 Such high relaxivities have been ascribed to 2 exchanging inner 
sphere water molecules coupled to (complete) chelate rigidity. Relaxivity was limited 
by slow water exchange. In fact, most systems reported to date use Gd3+ chelates based 
on, facile to synthesize, DTPA-(bis)amide6,7,8 and DOTA-monoamide12 ω-thiol ligands. 
Besides compromising the thermodynamic and kinetic stability of the chelates, critical 
for in vivo applications,13 amides display slow water exchange, in relation to their parent 
carboxylate chelates,14 limiting the relaxivity potentially achievable by rigid slow 
tumbling nanoparticles.11 As far as we know, the effect of water exchange on the 
relaxivity of Au-NPs functionalized with Gd3+ chelates has not been explicitly 
addressed. We have reported recently the synthesis of a novel macrocyclic metal 
chelator of the DOTA-type- DO3A-N-α-aminopropionate. The Gd(DO3A-N-α-
aminopropionate) chelate revealed exceptional inertness towards transmetallation, 
stability in a wide pH range (2-10) and fast water exchange, in the range considered 
ideal for attaining high relaxivities at intermediate fields.  
The pendant amine group on the propionate arm can be used for conjugation 
purposes.15 Building on these results, we have demonstrated meanwhile that Gd3+ 
chelates of amide conjugates of the DO3A-N-α-aminopropionate chelator retain the fast 
water exchange and stability properties of its parent complex.15,16 A cystein conjugate of 
the DO3A-N-α-aminopropionate ligand (5) (Scheme 1) was designed for decorating 
gold nanoparticles with Gd3+ chelates. Orthogonally protected prochelator 2 was 
synthesized in 3 steps from cyclen 115 (Scheme 1).   
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Scheme 1. Synthesis of cysteine conjugate DO3A-N-(α-cystamido)propionate (4) and 
preparation of gold nanoparticles functionalized with Gd(DO3A-N-(α-cystamido)propionate) 
chelates (5): a) i. TFA/DCM; ii. DIPEA/DCM, N-Boc-S-Trt-Cys, DCC/HOBt b) i. aqueous 
HCl, ii. Dowex1X2OH- resin, elution with hydrochloric acid 0.1M; c) i. aqueous HAuCl4, 
NaBH4, ii) GdCl3.6H2O, iii) SEC- Sephadex G10, iv) dialysis- cellulose membrane MWCO 
1000.  
The amine group on compound 2 can be made available for conjugation by 
orthogonal deprotection with TFA. Conjugate 4 was prepared in reasonable yield, as a 
mixture of diastereoisomers, by coupling amine-deprotected bifunctional pro-chelator 2 
with N-Boc-S-trityl cysteine using standard coupling conditions: DIPEA/DCC/HOBt. 
Purified amide was deprotected by sequential treatment with hydrochloric acid followed 
by Dowex1X2-OH- resin and resin elution with diluted hydrochloric acid. Conjugate 4 
was obtained as thiol, presumably due to the acidic conditions used for deprotection and 
resin elution. Gold nanoparticles functionalized with chelator 4 were prepared in 
aqueous medium using a modification of Brust´s method.17A molar equivalent of Gd3+, 
in relation to the amount of chelator used for nanoparticle preparation, was used to 
ensure complete loading of immobilized chelators.  
A final purification step by Size Exclusion Chromatography (SEC) (Sephadex 
G10) followed by extensive dialysis (cellulose membrane MWCO 1.000) against water 
afforded the final nanoparticle preparation, free of soluble complex and Gd3+ions. No 
attempt was made to fractionate the sample during SEC purification. The NPs are stable 
over extended time periods. They can be freeze-dried (and even rota-evaporated) and re-
dissolved in water without any apparent aggregation and precipitation. Dynamic light 
scattering (DLS) analysis (Figure 3ASI) revealed nanoparticles displaying an average 
hydrodynamic diameter of about 3.9 nm. Transmission electron microscopy (TEM) 
analysis (Figure 4SI) confirmed this result showing spherical highly crystalline 
particles. The Au and Gd content of the NPs preparation were determined by 
inductively coupled plasma mass spectrometry (ICP-MS) analysis after digestion with 
aqua regia ([Au]= 3.77 mM; [Gd]= 1.24 mM; ratio Au/Gd=2.9). The thickness of the 
chelator monolayer on Au NPs displaying an hydrodynamic diameter (determined by 
DLS) of 4.8 nm has been estimated by molecular modeling as being around 1.3 nm.11 
Taking into consideration the structural differences between the chelates and linkers 
reported and the ones disclosed in this work, one could estimate the gold core diameter 
of our nanoparticles as around 1.9 nm. From these results, one can calculate that the Au 
core contains on average 210 Au atoms and the organic monolayer 70 Gd3+ chelates. A 
rough estimation gives that nearly all Au atoms at the surface are bonded to gadolinium 
chelates. The stability of the immobilized chelates regarding transmetallation against 
Zn2+, the most abundant endogenous metal ion, was evaluated by relaxometric 
measurements (25 ºC, 20 MHz) using the protocol established for soluble 
Gd3+chelates.18 The gold nanoparticles were challenged with phosphate buffer and 
phosphate buffer containing Zn2+ ions. The time evolution of the relaxivity (Figure 
7BSI) suggests that virtually no transmetallation occurs over 30 hours. Moreover, the 
relaxivity is nearly constant in the pH range 2-12, indicating that immobilized chelates 
are stable (Figure 7ASI). Importantly, these assays evaluate also (whole) nanoparticle 
stability towards metal ion (Zn2+) and pH induced nanoparticle aggregation and 
precipitation, which would be apparent as time dependent relaxivity decrease. These 
results strongly suggest that the nanoparticles are safe for in vivo use, although further 
studies are necessary to evaluate chelate and nanoparticles stability in high protein 
media such as serum.  
The nuclear magnetic relaxation dispersion (NMRD) profile was measured in 
the Larmor frequency range 0.01-400 MHz and fitted to the Solomon-Bloembergen-
Morgan (SBM) theory including Lipari-Szabo treatment for internal rotation (Figure 
1).19 
 
Figure 1. 1H nuclear magnetic relaxation dispersion profiles for gold nanoparticles 
functionalized with Gd(DO3A-N-(α-cystamido)propionate complex (5 mM): 25 °C (), and 
37°C (). 
 
It was not possible to fit the whole NMRD profile, only frequencies above 6 
MHz were fitted, as the SBM theory does not work properly at low magnetic fields for 
slow rotating objects. The best fit parameters obtained for the Au NPs from the analysis 
of 1H NMRD data are shown in Table 1. 
Table1. Best fit parameters obtained for Au NPs  
functionalized with Gd(DO3A-N-(α-cystamido)propionate)  
chelates from the fitting of the 1H NMRD data.a,b 
Parameters Value 
q(H2O) 1 
∆H‡ [J/mol] 17c 
kex298 [107 s-1] 5.14c 
ER [kJ/mol] 
(global) 
18 ± 1.3 
τRH
298[ps] 
(global) 
2470 ± 151 
ER [kJ/mol] 
(local) 
18 
τRH
298[ps] 
(local) 
177 ± 27 
S2 0.48 ± 0.02 
EV [kJ/mol] 1 
τV
298
 [ps] 11 ± 1 
∆2 [1020 s-2] 0.040 ± 0.003 
aParameters underlined have been fixed; ba full list 
of parameters is given in Table 1SI; cref. 16 
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The water exchange rate constant and the activation enthalpy for water exchange were 
fixed in the fittings to values (kex298= 5.14x107 s-1 and ∆H‡= 17 J/mol) determined by us 
for the analogous low molecular weight chelate Gd(DO3A-N-(α-
benzoylamido)propionate).16 As far as we are aware, there are no reports in the literature 
on the measurement of the exchange rate on Gd3+ chelates immobilized on gold 
nanoparticles. Several authors have reported independently that kex for the CA MS-325 
drops by a factor of 2-3 upon binding to HSA.20 Non-covalent (non-specific) association 
of Gd3+ chelates to hydrophobic pockets on large proteins (HSA) is bound to restrict 
water access to chelates. In the case of Au NPs, gadolinium chelates are covalently 
bound, in a well defined orientation, to the nanoparticles surface via a relatively long 
linker, ensuring unrestricted water access to chelates. It is thus reasonable to assume 
that the immobilization has no effect on the water exchange rate. Other parameters were 
fixed to values characteristic of DOTA-type chelates. The NMRD profile is 
characteristic of slow-rotating particles with a shallow decrease of r1 at about 1 MHz 
and a broad peak centered at 20-30 MHz.11,21 Exceptional relaxivities per Gd3+ chelate 
(29 mM-1s-1, 30 MHz, 25 ºC) were obtained comparing to other q=1 systems reported 
before.6-10,12 The temperature dependence of relaxivity at high field reveals that r1 is not 
limited by water exchange. In fact, kex298 can be varied a lot in simulations without 
influencing the results. Chelate flexibility seems to be the main factor limiting 
relaxivity. In fact, the “modified Florence method”,22 which assumes (total) chelate 
rigidity is not suitable for fitting the NMRD data. The Lipari-Szabo treatment for 
internal rotation used in the fitting reveals a long global (whole particle) rotational 
correlation time (τRH298global= 2470 ps) and a short local rotational correlation time 
(τRH298local= 177 ps). The order factor value (S2= 0.48) is of the same order of magnitude 
as those reported before for micellar systems, reflecting chelate flexibility.21 This is 
somehow surprising considering the short (cystein) linker used for chelate 
immobilization. However, the structure of the linker might limit monolayer packing 
density, which could otherwise restrict local movements.9,10 The (unprecedented) high 
relaxivity per Gd3+ attained at intermediate field (29mM-1s-1, 30 MHz, 25 ºC) together 
with the inertness and stability of the chelates and whole nanoparticles suggest that this 
system is promising for biological applications. It is also worth noting that the relaxivity 
peak at intermediate field is very broad extending into the high field region.  
Relaxivity values at 100 and 200 MHz (15 and 8 mM-1	s-1, respectively, at 37 ºC) are 
still remarkable for biological applications as a high field CA.23 The relaxivity displayed 
by the system described by Helm and co-workers is limited by slow water exchange 
(rigid system, S2= 1). For the system described here, at magnetic fields relevant for MRI 
the relaxivity is limited by the flexibility of the linker used to bind the chelate to the 
nanoparticle (Fig. 8SI). Metal ion mediated self-assembly of Gd3+ complexes into rigid 
metallostars,24 placement of Gd3+ chelates on the barycenter of sugar constructs25 and 
anchoring Gd3+ chelates functionalized with two alkyl chains into micelles26,27 have 
been successful strategies for coupling local and global motions. It is thus conceivable, 
that Gd3+chelates of conjugates of the DO3A-N-α-aminopropionate chelator, bearing 
long thiol linkers able to self-assemble into dense packing, rigid monolayers on Au, 
might attain unprecedented high relaxivities. The relaxation enhancement generated at 
37°C and 1.5 T (60 MHz) by our Au-NPs is about 1,400 mM-1	s-1 and therefore a local 
700 nM concentration of particles would still lead to a relaxation enhancement of 1s-1. 
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Suplementary information 
Materials and methods 
Chemicals were purchased from Sigma-Aldrich and used without further purification. 
Cyclen was purchased from Chematech, France. Analytical grade solvents were used 
and, unless specified,not further purified. Reactions were monitored by TLC on silica 
gel by examination under UV light (250 nm) and staining with iodine vapour. 
Preparative chromatography was carried on Silica Gel 60 (230-400 mesh). Ion exchange 
chromatography was performed on Dowex 1X2 OH- (50-100 mesh) resin. Size 
Exclusion Chromatography (SEC) was performed on Sephadex G10 (40-120 µm). 
Dialysis was performed against water on cellulose membranes with MWCO of 1KDa. 
UV-VIS spectra were acquired with a Shimadzu UV-2501PC spectrophotometer. The 
size distribution and zeta potential of the gold nanoparticles were determined with a 
Malvern Zetasizer, NANO ZS (Malvern Instruments Limited, UK), using a He-Ne laser 
(wavelength of 633 nm) and a detector angle of 173º. Mass spectrometry was performed 
at CACTI- Vigo, Spain. 1H and 13C NMR spectra were run on Varian Unity Plus 300, 
Bruker Avance-3 400 Plus and Varian VNMRS 600 NMR spectrometers. Chemical 
shifts (δ) are given in ppm relative to the CDCl3 solvent (1H, δ 7.27; 13C 77.36) as 
internal standard. For 1H and 13C NMR spectra recorded in D2O, chemical shifts (δ) are 
given in ppm, respectively, relative to TSP as internal reference (1H, δ 0.0) and tert-
butanol as external reference (13C, CH3 δ 30.29). 13C NMR spectra were proton broad-
band decoupled using a GARP-1 modulated decoupling scheme.  
The 1H Nuclear Magnetic Resonance Dispersion (NMRD) measurements were 
performed by using a Stelar Spinmaster FFC NMR relaxometer (0.01-20 MHz) 
equipped with a VTC90 temperature control unit. At higher fields, the 1H relaxivity 
measurements were performed on Bruker Minispecs mq30 (30 MHz), mq40 (40 MHz) 
and mq60 (60 MHz), as well as Bruker Avance spectrometers connected to 2.35 T, 4.7 
T and 9.4 T superconducting magnets. In each case, the temperature was measured by a 
substitution technique. Variable temperature measurements were performed at 25 and 
37 ºC. The relaxometric pH dependence and transmetallation studies with Zn2+ of the 
nanoparticles were performed on a Bruker Minispec mq20 (20 MHz). The NMRD 
profiles have been analysed using the Visualiseur/Optimiseur 3.6 program1 running on a 
Matlab® 6.5 platform.  
Synthesis and characterization 
 
Preparation of the DO3A-N-(α-cystamido)propionate ligand (4): 
 
Synthesis of amide (3): Orthogonally protected cyclen 22 (1.62 g, 2.21 mmol) 
was dissolved in a mixture of dichlorometane/trifluoroacetic acid (45 cm3, 1/3 v/v) and 
stirred overnight at room temperature. The solvent was evaporated at reduced pressure 
and the residue was re-dissolved in dichlorometane and evaporated again. This 
procedure was repeated several times to give a thick light yellow oil. 1H NMR 
spectroscopy (CDCl3) revealed the disappearance of the signals assigned to the Boc 
groups in precursor compound 2. The integration ratio between the methine proton 
NCH2CH and the methyl or methylene protons (from the ethyl ester groups) indicated 
that no deprotection of the ethyl ester groups occurred. Amine deprotected compound 
(2) (2.21 mmol, assuming quantitative deprotection) was dissolved in dicholorometane 
(30 cm3). The solution was adjusted to pH 8-9 (pH paper) by dropwise addition of 
DIPEA (~7.0 cm3). To this solution was sequentially added N-Boc-S-trityl-L-cysteine 
(1.02 g, 2.21 mmol), Hydroxybenzotriazole (0.557 g, 2.64 mmol) and a solution of DCC 
(0.752 g, 2.64 mmol) in dichloromethane (5 cm3). The reaction mixture was left stirring 
at room temperature overnight. The DCU byproduct was removed by filtration and the 
sample was concentrated under reduced pressure. The residue was re-dissolved in ethyl 
acetate (100 cm3), and the solution was washed sequentially with KHSO4 (1M, 3 x 30 
cm3), NaHCO3 (saturated solution, 3 x 30 cm3) and brine (3 x 30 cm3). The organic 
phase was concentrated under reduced pressure and the residue was purified by a flash 
chromatography (100% CH2Cl2 → CH2Cl2/EtOH (70:30)) to afford amide (3) (0.736 g, 
34%). 1H NMR (300 MHz, CDCl3): δ= 1.26 (m, 9 H, C(O)OCH2CH3), 1.46 (s, 9H, 
C(CH3)3), 2.2-3.60 (broad, overlapped signals with a integration corresponding to 26 H; 
N(CH2)2N, NCH2CO2Et, NHBocCHaHbCH, NCHaHbCH), 3.80 (s, 3H, C(O)OCH3), 
4,15 (m, 6H, OCH2CH3), 4.77 (m (br), 1H, NHBocCHaHbCH), 5.87 (m (br), 1H, 
NCHaHbCH), 7.1-7.6 (m, 15 H, Trt). HRMS (ESI): m/z: cacd for C51H73N6O11S 
[M+H]+: 977.5058, found: 977.5021. 
 
 
Preparation of fully deprotected DO3A-N-(α-cystamido)propionate metal 
chelator (4): Compound (3) (0.706 g, 0.722 mmol) was dissolved in hydrochloric acid 
3 M (20 cm3; water (5 cm3)/ethanol (10 cm3)/hydrochloric acid 37% (5 cm3)). The 
solution was left stirring at room temperature overnight. The solvent was removed 
under reduced pressure at room temperature and the residue was taken up into a small 
volume of water (~ 20 cm3) and filtered. The solution was concentrated at reduced 
pressure, the residue was dissolved in water (~ 15 cm3) and the solution was adjusted to 
pH ~ 10-11 by adding small portions of Dowex 1X2-100-OH- resin. The suspension 
was kept under stirring at room temperature for 2 hours. The wet resin was transferred 
into a chromatography column, washed with water (~ 50 cm3) and eluted with 0.1 M 
hydrochloric acid. The relevant fractions, identified by TLC (ethanol water 1/1, 
revelation with iodine vapor) were pooled, concentrated at room temperature and further 
dried under vacuum to afford the final deprotected compound (4) in the hydrochloride 
form, as a light yellow solid (0.276 g, 71.2%). 1H NMR (300 MHz, D2O): δ= 2.2-4.40 
(broad, overlapped signals with an integration corresponding to, 22 H: N(CH2)2N and 
NCH2COOH), 3.07 (m, 2H, CH2SH), 3.33 (m, 2H, CH2CH), 4.22 (m, 1H, CH2CH), 
4.61 (m, 1H, SHCH2CH). 13C NMR (75.4 MHz, D2O): selected signals: 22.14 (CH2SH), 
46.34 (CH2), 47,63 (CH2), 48.16 (CH2), 48.69 (CH2), 49.98 (CH2), 51.01 (CH2), 53.43 
(CH2), 53.80 (CH2CH), 54.03 (CHCH2SH), 54.14 (CH2), 54.27 (CH2), 55.15 (CHCH2), 
56.09 (CH2), 169.03 (NHC(O)), 169.14 (C(O)), 170.60 (C(O)), 176.61 (CHC(O)), 
177.93 (C(O)). HRMS (ESI): m/z: cacd for C20H37N6O9S [M+H]+: 537.2343, found: 
537.2325.  










Preparation gold nanoparticles functionalized with Gd(DO3A-N-(α-
cystamido) propionate) chelates: The strategy envisaged for preparing gold 
nanoparticles funcionalized with Gd(DO3A-N-α-(cystamido)propionate) chelates is 
depicted (as cartoon) in Scheme 1SI).   
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Scheme 1SI. General strategy (cartoon representation) for the preparation of gold nanoparticles 
functionalized with Gd(DO3A-N-(α-cystamido)propionate) chelates. 
 
An aqueous solution of DO3A-N-(α-cystamido)propionate (4) ligand (46.13 
mM, 4.66 cm3, 0.099 mmol) was added dropwise, under magnetic stirring, to an 
aqueous solution of HAuCl4 (58.85 mM, 1.64 cm3, 0.096 mmol; molar ratio Au/ligand 
(1/1)). Addition of the ligand to the Au3+ solution generated initially a dark orange color 
which faded away with further ligand addition. To the stirring reaction mixture was 
added, in one aliquot, a solution of NaBH4 (20.40 mM, 0.217 cm3, 0.094 mmol; molar 
ratio Au/ligand/NaBH4 1/1/1). The reaction mixture turned immediately dark brown and 
was left stirring at room temperature for 24 hours. The nanoparticles preparation was 
adjusted to pH ~ 7.0 with aqueous NaOH 1 M and filtered through a 0.20 µm PTFE 
syringe filter. A small sample (1.0 cm3) was kept for further characterization. To the 
remaining sample (~ 6.0 cm3) was added a solution of GdCl3.6H2O (0.0211 g, 0.080 
mmol; 1 molar equivalent in relation to the total amount of ligand used in the 
nanoparticles synthesis) in water (1.0 cm3). During the addition of the Gd3+ ion the 
solution was kept at pH ~ 5.5 by adding NaOH 0.1 M. The reaction mixture was left 
stirring at room temperature for 24 hours, adjusted to pH ~7 by with aqueous NaOH (1 
M solution) and filtered through a 0.20 µm PTFE syringe filter. The gold nanoparticle 
preparation was purified by size exclusion chromatography using Sephadex G10 (40-
120 µm) eluting with water.  
During elution a colored broad band separated in the column. No attempt was 
made to fractionate the sample, the full band was collected as a single fraction (~ 20 
cm3). The nanoparticles preparation was further purified by dialysis against water using 
a cellulose membrane with 1 KDa MWCO. The xylenol orange test indicated the 
absence of free Gd3+ in the gold nanoparticles preparation. The Gd and Au 
concentration of the nanoparticle´s preparation ([Au]= 3.77 mM; [Gd]= 1.24 mM; 
[Au]/[Gd]= 2.9) was determined by ICP analysis.  
The binding mode of the Gd(DO3A-N-(α-cystamido)propionate) chelates to the 
gold  surface, represented in Scheme 1SI through the tiol group of the cysteine linker, is 
the most likely anchorage mode. Several authors have suggested the simultaneous 
binding of the thiol and amine groups of cystein to gold (forming a chelate ring) as the 
(most likely) anchorage mode of cystein containing peptides to gold NPs.3. The band at 
3500 cm-1 in the IR spectrum (KBr pellets) of our nanoparticles (Figure 1SI) is assigned 
by several authors to vibrational modes of the -NH3+ group in cystein functionalized 
gold nanoparticles.4  
 
Figure 1SI. IR spectrum (KBr) of gold NPs functionalized with Gd(DO3A-N-
(α-cystamido)propionate) chelates  
 
The IR spectrum of the functionalized gold NPs suggests that the nanoparticles 
are linked to the gold core through the thiol group only. The broad band at around 3500 
cm-1 has been assigned to vibrational modes of the -NH3+ in cystein functionalized gold 
NP´s.3,4 If the amine group is not involved in the binding to gold, then the effect of the 
solution pH on the overall charge of the immobilized complexes should be apparent as a 
pH-dependent zeta potential.  
The negative Zeta potential values measured at pH 7.0 and 10.0 (Figure 3BSI) 
suggest that the chelates (and whole nanoparticles) bear net negative charges. Moreover, 
the value and shape of the Zeta potential distribution curves at pH 7.0 and 10.0 suggests 
a higher extent of ionization of the amine group at pH 10. None the less the putative 
ionization of the amine group seems not to affect substantially the relaxivity of the NP´s 
in the pH range 2-12 (Figure 7ASI). 
 
UV-VIS spectroscopy 
A very ill-defined plasmon band is apparent in the UV-VIS spectrum of the gold 
nanoparticles functionalized with Gd(DO3A-N-(α-cystamido)propionate) chelates, 
suggesting that the nanoparticles display a diameter bellow 6 nm.  

Figure 2SI. UV-VIS spectrum for the preparation of nanoparticles functionalized with 
Gd(DO3A-N-(α-cystamido)propionate) chelates (diluted by a factor of 3, pH 7.0).  
 
 
 
 
 
 
 
 
 
 
 
 
Size and zeta potential characterization by DLS 
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Figure 3ASI. DLS size distribution (Volume) for the preparation of nanoparticles 
functionalized with Gd(DO3A-N-(α-cystamido)propionate) chelates at pH 7.0.  
 
From the DLS experiments (Figure 3ASI), one can conclude that the main population of 
nanoparticles in solution displays an average hydrodynamic diameter around 3.9 nm.   


Figure 3BSI. Zeta potential distribution at pH 7.0 (red curve) and pH 10.0 (green curve) for the 
preparation of nanoparticles functionalized with Gd(DO3A-N-(α-cystamido)propionate) 
chelates. 
Figure 3BSI shows that the nanoparticles display negative zeta potential both at pH 7.0 
and pH 10.0, with a broader distribuition at pH 7.0.   
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TEM characterization of the nanoparticles 


Figure 4SI. TEM images of the Au-NPs. The images were acquired with a JEOL 2010 UHR 
transmission electron microscope at the Interdisciplinary Centre for Electron Microscopy 
(CIME) at EPFL, Lausanne. TEM samples have been prepared by dropping solutions of gold 
nanoparticles onto carbon-coated-copper grids and evaporating the solvent (water) to dryness. 
Estimation of the number of Au atoms 
The diameter of the Au-core of the gold nanoparticles has been estimated by choosing 
the thickness of the organic layer at the surface as 1 nm. This layer should be less 
thicker than in ref. 6 because there are only 4 connecting atoms between the N in the 
chelate and the S at the Au surface compared to 5 in ref. 6. The Au-core has therefore a 
diameter of ~1.9 nm. Following ref. 7 the total number of Au atoms can be estimated to 
be ~210 from NAu = 30.9	D3. Taking the experimental Au/Gd ratio of 2.9 there are ~70 
Gd3+-ions bound to a particle which corresponds roughly to 1 Gd3+ ion per gold atom at 
the surface. 
 
Relaxometric characterization of the gold nanoparticles 

Figure 5SI. Dependence of the proton longitudinal paramagnetic relaxation rates (R1p) on the 
Gd3+ concentration for the preparation of nanoparticles functionalized with Gd(DO3A-N-(α-
cystamido)propionate) chelates (20 MHz, 25 ºC, pH 7.5). Preparations with different 
concentrations Gd3+ were obtained by dilution of the stock solution [Gd3+]= 1.238 mM. 
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Figure 6SI. Dependence of the 
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Figure 7BSI. Time evolution of the relative water proton paramagnetic relaxation rate 
R1p(t)/R1p(0) (20 MHz, 37 ºC) for the preparation of nanoparticles functionalized with 
Gd(DO3A-N-(α-cystamido)propionate) chelates ([Gd3+] = 0.928 mM) in PBS 2.5 mM, pH 7.1 
in the presence (●) and in the absence (♦) of 0.75 mM ZnCl2.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Fitting of NMRD profiles 
Table 1SI. Full list of parameters used for the fitting of the high-field part of the NMRD 
profiles using SBM theory. 
Parameters Value 
q(H2O) 1 
∆H‡ [J/mol] 17a 
kex298 [107 s-1] 5.14a 
ER [kJ/mol] (global) 18 ± 1.3 
τRH
298[ps] (global) 2470 ± 151 
ER [kJ/mol] (local) 18b 
τRH
298[ps] (local) 177 ± 27 
S2 0.48 ± 0.02 
EV [kJ/mol] 1 
τV
298
 [ps] 11 ± 1 
∆2 [1020 s-2] 0.040 ± 0.003 
rGdH [Å] 3.1c 
DGdH298[10-10 m2s-1] 23c 
EDGdH298[kJ/mol] 20c 
d [Å] 3.6c 
Parameters underlined have been fixed: a from reference 5; b fixed to 
ER(global) after a preliminary fit, c fixed to usual parameters   


Figure 8SI. 1H nuclear magnetic relaxation dispersion profiles for gold nanoparticles 
functionalized with Gd(DO3A-N-(α-cystamido)propionate complex (5 mM): 25 °C (□), and 
37°C (○). The full drawn lines are from the fit with parameters in Table 1SI. The dashed lines 
are calculated using the same parameters except S2 = 1. 
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